WILMINGTON, Del., April 23, 2015 /PRNewswire/ -- The Chemours
Company ("Chemours") announced today the offering, subject to
market and other conditions, of approximately $2,125 million aggregate principal amount of
senior unsecured dollar-denominated Notes and €350 million
aggregate principal amount of senior unsecured Euro-denominated
Notes (together, the "Notes"). Chemours is a wholly owned
subsidiary of E. I. du Pont de Nemours and Company ("DuPont").
The Notes offering is being launched by Chemours in anticipation
of the DuPont proposed pro rata distribution of Chemours common
stock to its stockholders (the "Separation"), and of Chemours'
expected distribution of approximately $4,000 million to DuPont prior to the Separation,
as more fully described in Chemours' information statement filed as
Exhibit 99.1 to its amended Registration Statement on Form 10 filed
by Chemours with the Securities and Exchange Commission (the "SEC")
on April 21, 2015.
The Notes will not be registered under the Securities Act of
1933, as amended (the "Securities Act"), or any state securities
law, and may not be offered or sold in the United States absent registration or an
applicable exemption from registration under the Securities Act and
applicable state securities laws. The Notes will be offered only to
persons reasonably believed to be qualified institutional buyers
under Rule 144A under the Securities Act and to non-U.S. persons in
compliance with Regulation S under the Securities Act. This
press release does not constitute an offer to sell any security and
shall not constitute an offer, solicitation or sale in any
jurisdiction in which such offer or sale would be unlawful.
After the Separation from DuPont, Chemours will be an
independent, publicly traded company and a global provider of
performance chemicals through three reporting segments: Titanium
Technologies, Fluoroproducts and Chemical Solutions. Chemours
delivers customized solutions with a wide range of industrial and
specialty chemical products for markets including plastics and
coatings, refrigeration and air conditioning, general industrial,
mining and oil refining. Principal products include titanium
dioxide, refrigerants, industrial fluoropolymer resins and a
portfolio of industrial chemicals including sodium cyanide and
sulfuric acid. Chemours, based in Wilmington, Delaware, has approximately 9,100
employees and 37 production facilities in 12 countries, and serves
more than 5,000 customers worldwide.
DuPont (NYSE: DD) has been bringing world-class science and
engineering to the global marketplace in the form of innovative
products, materials, and services since 1802. The company believes
that by collaborating with customers, governments, NGOs, and
thought leaders we can help find solutions to such global
challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment.
Forward-Looking Statements
This document contains
forward-looking statements which may be identified by their use of
words like "plans," "expects," "will," "believes," "intends,"
"estimates," "anticipates" or other words of similar meaning. All
statements that address expectations or projections about the
future, including statements about growth strategies, product
development, regulatory approval, market position, anticipated
benefits of recent acquisitions, timing of anticipated benefits
from restructuring actions, outcome of contingencies, such as
litigation and environmental matters, expenditures and financial
results, are forward looking statements. Forward-looking statements
are not guarantees of future performance and are based on certain
assumptions and expectations of future events which may not be
realized. Forward-looking statements also involve risks and
uncertainties. Some of the important factors that could cause
actual results to differ materially from those projected in any
such forward looking statements are: (i) risks related to the
anticipated timing of the Separation and the Notes offering, (ii)
risks that the conditions to the Separation, including the Notes
offering and related financing transactions, are not satisfied,
(iii) the use of proceeds from the Notes offering and (iv)
additional factors described in DuPont's and Chemours' filings with
the SEC. Neither DuPont nor Chemours undertakes any duty to update
such forward-looking statements as a result of future developments
or new information.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-chemours-company-announces-launch-of-senior-notes-offering-300070892.html
SOURCE DuPont